Managing the Diabetic Foot

Overview

Written by the BMA award-winning author team of Mike Edmonds and Alethea Foster

Aimed at podiatrists, nurses, physicians, surgeons, orthotists and all other members of the multidisciplinary diabetic foot team, Managing the Diabetic Foot, Second Edition, remains a “must-have” for all those interested in ...

See more details below
Available through our Marketplace sellers.
Other sellers (Paperback)
  • All (4) from $75.18   
  • Used (4) from $75.18   
Close
Sort by
Page 1 of 1
Showing All
Note: Marketplace items are not eligible for any BN.com coupons and promotions
$75.18
Seller since 2009

Feedback rating:

(49)

Condition:

New — never opened or used in original packaging.

Like New — packaging may have been opened. A "Like New" item is suitable to give as a gift.

Very Good — may have minor signs of wear on packaging but item works perfectly and has no damage.

Good — item is in good condition but packaging may have signs of shelf wear/aging or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Acceptable — item is in working order but may show signs of wear such as scratches or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Used — An item that has been opened and may show signs of wear. All specific defects should be noted in the Comments section associated with each item.

Refurbished — A used item that has been renewed or updated and verified to be in proper working condition. Not necessarily completed by the original manufacturer.

Very Good
2000 Paperback Very Good: a copy that has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged. Most ... items will be dispatched the same or the next working day. *****PLEASE NOTE: This item is shipping from an authorized seller in Europe. In the event that a return is necessary, you will be able to return your item within the US. To learn more about our European sellers and policies see the BookQuest FAQ section***** Read more Show Less

Ships from: Haslingden, United Kingdom

Usually ships in 1-2 business days

  • Canadian
  • Standard, 48 States
  • Standard (AK, HI)
$80.58
Seller since 2012

Feedback rating:

(56)

Condition: Acceptable
2000 This is an ex-library book and may have the usual library/used-book markings inside. This book has soft covers. In fair condition, suitable as a study copy., 300grams, ... ISBN: 0632055839. *****PLEASE NOTE: This item is shipping from an authorized seller in Europe. In the event that a return is necessary, you will be able to return your item within the US. To learn more about our European sellers and policies see the BookQuest FAQ section***** Read more Show Less

Ships from: Lincoln, United Kingdom

Usually ships in 1-2 business days

  • Canadian
  • Standard, 48 States
  • Standard (AK, HI)
$228.18
Seller since 2014

Feedback rating:

(265)

Condition: Good
Possible retired library copy, some have markings or writing. May or may not include accessories such as CD or access codes.

Ships from: Chatham, NJ

Usually ships in 1-2 business days

  • Canadian
  • International
  • Standard, 48 States
  • Standard (AK, HI)
  • Express, 48 States
  • Express (AK, HI)
$228.20
Seller since 2014

Feedback rating:

(265)

Condition: Very Good
Very good.

Ships from: Chatham, NJ

Usually ships in 1-2 business days

  • Canadian
  • International
  • Standard, 48 States
  • Standard (AK, HI)
  • Express, 48 States
  • Express (AK, HI)
Page 1 of 1
Showing All
Close
Sort by
Managing the Diabetic Foot

Available on NOOK devices and apps  
  • NOOK Devices
  • NOOK HD/HD+ Tablet
  • NOOK
  • NOOK Color
  • NOOK Tablet
  • Tablet/Phone
  • NOOK for Windows 8 Tablet
  • NOOK for iOS
  • NOOK for Android
  • NOOK Kids for iPad
  • PC/Mac
  • NOOK for Windows 8
  • NOOK for PC
  • NOOK for Mac
  • NOOK Study
  • NOOK for Web

Want a NOOK? Explore Now

NOOK Book (eBook)
$37.99
BN.com price
(Save 42%)$65.95 List Price
This digital version does not exactly match the physical book displayed here.

Overview

Written by the BMA award-winning author team of Mike Edmonds and Alethea Foster

Aimed at podiatrists, nurses, physicians, surgeons, orthotists and all other members of the multidisciplinary diabetic foot team, Managing the Diabetic Foot, Second Edition, remains a “must-have” for all those interested in diabetes and the diabetic foot.


New features of this Second Edition include:

  • Chapter on amputation has been expanded as has the overall surgical focus
  • Metabolic control and all other aspects of management have also been extensively updated
  • New introductory chapter which describes the assessment of the diabetic foot, incorporating an illustrated section on differential diagnosis
  • Content aids the implementation of the NICE guidelines and the ‘National Service Framework for Diabetes’

The book contains predominantly color illustrations, with some black-and-white illustrations.

Read More Show Less

Editorial Reviews

From The Critics
Reviewer: Martin C. Yorath, DPM(Rosalind Franklin University of Medicine and Science)
Description: This pocket-sized book provides a succinct overview of the challenging and complex area of clinical management of the diabetic foot. The first edition was published in 2000.
Purpose: The purpose is to reinforce the multidisciplinary approach that is necessary with diabetic patients, and while there are several on this subject, there are few, if any which provide this type of breadth in such a small volume. The concept of early diagnosis and treatment is reinforced throughout.
Audience: Aimed at all involved in the management of the diabetic foot, both medical and nonmedical, the book sends its message to the target audiences well. Michael Edmonds and Ali Foster are a British Medical Association co-author award winning team, and are well respected within this field.
Features: The book is arranged into six sections, covering all of the clinical conditions from the "normal" diabetic foot through to the unsalvageable foot. Each section is color coded for easy reference, with an appendix covering differential diagnosis for the foot in diabetes. Overall, it is a very easy book to use and read. Color photography is extensively used throughout, and imaging studies are well reproduced. Tables are frequently used as well. References are not cited, but there is a short further reading list at the end of the book.
Assessment: This is an excellent book, and while there are more extensive books available, few are able to put it together as neatly and simply as this one does. The second edition is justified for its enhanced coverage of the neuropathic foot, metabolic management, amputee management, and some aspects of surgical management. While clearly aimed at the U.K. market, the general principles discussed here are just as valid in the United States. It is highly recommended.
Read More Show Less

Product Details

  • ISBN-13: 9780632055838
  • Publisher: Wiley, John & Sons, Incorporated
  • Publication date: 4/17/2000
  • Edition description: Older Edition
  • Edition number: 1
  • Pages: 134
  • Product dimensions: 4.76 (w) x 7.52 (h) x 0.28 (d)

Meet the Author

Michael E Edmonds MD FRCP, Consultant Physician, Diabetic Foot Clinic, King’s Diabetes Centre, King’s College Hospital, London, UK. Dr Edmonds is a world-renowned expert on foot problems in diabetes. He has lectured on the topic throughout the world and gave the inaugural Roger Pecoraro Lecture at the American Diabetes Association's annual meeting. He is also Chairman of the Diabetic Foot Study Group of the European Association for the Study of Diabetes.

Alethea V M Foster BA(Hons) PGCE MChS SRCh DipPodM, Chief Podiatrist, Diabetic Foot Clinic, King’s Diabetes Centre, King’s College Hospital, London, UK. Alethea was involved in the development of the UK Government's National Service Framework for Diabetes which are being implement in all hospitals, clinics and primary care practices by April 2004. In May 2003, Alethea was the first podiatrist to be awarded the International Diabetic Foot Award, which is only awarded every four years to an individual who has played a pivotal role in developing diabetic foot care.

Two per cent of the world's population have diabetes and of these, ten per cent will have a foot ulcer at any one time. Foot ulcers in diabetics are difficult to treat and very slow to heal. They result in more amputations than any other pathology. Severe ulcers are very debilitating, often require hospitalisation (half of all diabetic patients in hospital have foot ulcers) and can even result in death through complications such as gangrene and septicaemia.

Foot problems in diabetic patients are very difficult to treat. Therefore visual recognition of presenting clinical signs is a vital component of early diagnosis and start of treatment. Treatment in this field is developing with the launch of 'synthetic' skin grafts such as Apligraf (Novartis).

In the UK, the Department of Health published guidelines for the National Service Framework for Diabetes in December 2001. Alethea Foster was involved in the development of these guidelines. They are to be implemented in all hospitals/clinics/GP practices by April 2004 and call for 'proficient, rapid foot care for patients'. This book will reflect the changes resulting from the implementation of these guidelines.

Although these guidelines are only those adopted in the UK, the book will have a global focus. The information presented will be relevant to anyone involved in treating diabetic patients.

The previous approach to the first edition, incorporating numerous practical tips on the day to day assessment and management of the diabetic foot (which are not covered in any other diabetic foot books) will be expanded and made more formal by including an appropriate section in each chapter on practical management hints.

There will be a new introductory chapter describing the assessment of the diabetic foot incorporating an illustrated section on differential diagnosis. However, the basic framework of the book will be similar to the first edition as follows: infected foot, necrotic foot and unsalvageable foot. However, each section will undergo substantial revision as described below:

Low-risk foot: new approaches to blood glucose control, lipids and blood pressure management, as demonstrated by recent landmark trials, will be incorporated. The use of statins, ACE inhibitors and anti-platelet agents all have new indications.

High-risk foot: section on neuropathy will be expanded to include new approaches to neuropathy management (PKC inhibitor, Eli Lily drug) and management of painful neuropathy (gabapentin, Pfeizer).

Ulcerated foot: notes on differential diagnosis will be added including squamous cell carcinomas and gouty ulcers which we have recently added to our collection: new approaches to management of ulceration including the VAC pump, Kerraboot (Ark therapeutics’ new product), the pulse compression boot, silver dressings, promogran, MPIs (metallo-protease inhibitors), maggots, and wound odour management with new therapies, will all be incorporated. New techniques of off-loading such as the PRAFO (Pressure-relieving ankle foot orthosis) and the knee scooter will be included, as will the time-honoured podiatric technique of adhesive felt padding. More practical details on manufacture and use of the Scotchcast boot for ischaemic ulceration will be covered.

Infected foot: an expanded section on infection will include detailed consideration of MRSA and new resistant gram negative microorganisms. The very early signs of infection will be elaborated upon and osteomyelitis will be revisited. The use of MRI in the assessment of the infected foot to detect collections of pus and osteomyelitis will be discussed. New therapies including Linezolid (Pfizer drug) will be discussed.

The necrotic foot: the vascular assessment and management will be updated including MRI and new angioplasty techniques such as sub-intimal angioplasty and outpatient day case angioplasty. Protection from contrast nephropathy will be discussed, highlighting acetyl cysteine and the withdrawal of dopamine therapy (no longer used, but discussed in the previous edition). New techniques of blood vessel closure following angioplasty, such as the perclose technique will be discussed. Implications of end stage renal failure will be covered in more detail.

The unsalvageable foot section will be greatly extended to cover details of rehabilitation and prostheses.

Throughout all the sections the educational element will be expanded.

A new section on Charcot’s osteoarthropathy will be written to incorporate new approaches to diagnosis and management, including the CROW walker and reconstructive surgery.

A new section will cover diabetic foot surgery.

Read More Show Less

Table of Contents

Acknowledgements vi
Preface vii
Introduction 1
Managing Stage 1 The normal foot 25
Managing Stage 2 The high-risk foot 35
Managing Stage 3 The ulcerated foot 45
Managing Stage 4 The cellulitic foot 77
Managing Stage 5 The necrotic foot 99
Managing Stage 6 The major amputation 113
Non-ulcerative pathologies 115
New developments 123
Appendix Problems of differential diagnosis 127
Further Reading 129
Index 131
Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)